Dudda J.C., Salaun B., Ji Y., Palmer D.C., Monnot G.C., Merck E., Boudousquie C., Utzschneider D.T., Escobar T.M., Perret R., Muljo S.A., Hebeisen M., Rufer N., Zehn D., Donda A., Restifo N.P., Held W., Gattinoni L. and Romero P.

Sep 6, 2013 | Publications

MicroRNA-155 is required for effector CD8(+) T cell responses to virus infection and cancer.
Immunity 2013, 38:742-753.